Home  About us  Contact
 

Editor In Chief (editor + in_chief)

Distribution by Scientific Domains
Medical Sciences55%

Kinds of Editor In Chief

  • journal editor in chief
    		•

    Selected Abstracts

    A note from the President of the International Society of Dermatology and the Editor in Chief

    INTERNATIONAL JOURNAL OF DERMATOLOGY, Issue 2007
    Ramón Ruiz-Maldonado MD
    No abstract is available for this article. [source]

    Farewell from the Editor in Chief

    JOURNAL OF SLEEP RESEARCH, Issue 1p2 2010
    Peretz Lavie Editor in Chief
    No abstract is available for this article. [source]

    Retracted: Antiaging effect of purslane herb aqueous extracts and its mechanism of Action

    PHYTOTHERAPY RESEARCH, Issue 9 2009
    Huang Hao
    The following article from Phytotherapy Research, Antiaging effect of purslane herb aqueous extracts and its mechanism of Action by Huang Hao, Yu Nancai, Fu Lei, Su Wen, Huang Guofu, Wu Yanxia, Huang Hanju, Liu Qian published online on 15th April 2009 in Wiley InterScience (www.interscience.wiley.com) has been retracted by agreement between the journal Editor in Chief, Elizabeth Williamson and John Wiley & Sons, Ltd. The retraction has been agreed due to overlap with the following article: Zhang Hongxing, Yu Nancai, Huang Guofu, Shao Jianbo, Wu Yanxia, Huang Hanju, Liu Qian, Ma Wei, Yi Yandong and Huang Hao. Neuroprotective effects of purslane herb aquenous extracts against d-galactose induced neurotoxicity. Chemico-Biological Interactions 170: 3, pp.145-152. Copyright © 2009 John Wiley & Sons, Ltd. [source]

    From the Editor in Chief

    POLICY STUDIES JOURNAL, Issue 4 2002
    Article first published online: 6 JUL 200
    No abstract is available for this article. [source]

    From the Editor in Chief

    POLICY STUDIES JOURNAL, Issue 3 2002
    Article first published online: 6 JUL 200
    No abstract is available for this article. [source]

    From the Editor in Chief

    POLICY STUDIES JOURNAL, Issue 2 2002
    Article first published online: 6 JUL 200
    No abstract is available for this article. [source]

    This article has been retracted: Safety Pharmacology, Acute Toxicity and Pharmacokinetics of SCP-123 and Acetaminophen

    BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY, Issue 2 2010
    Donna J. Millington
    The following article from Basic & Clinical Pharmacology & Toxicology, ,Safety Pharmacology, Acute Toxicity and Pharmacokinetics of SCP-123 and Acetaminophen' by Donna J. Millington, Cristina Villanueva, Jason Obirek, Jean Kaufman and Christopher Smith, published online on 12 April 2010 (DOI: 10.1111/j.1742-7843.2010.00562.x) in Wiley InterScience (http://www.interscience.wiley.com), has been retracted by agreement between the authors, the journal Editor in Chief, Kim Brøsen, and John Wiley and Sons A/S. The retraction has been agreed due to incorrect author affiliation. [source]

    Retracted: Determination of dextra,methylprednisolone conjugate with glycine linker in rat plasma and liver by high-performance liquid chromatography and its application in pharmacokinetics

    BIOMEDICAL CHROMATOGRAPHY, Issue 4 2010
    Shuang-Qing Zhang
    The following article from Biomedical Chromatography, Determination of dextra-methylprednisolone conjugate with glycine linker in rat plasma and liver by high-performance liquid chromatography and its application in pharmacokinetics by Shuang-Qing Zhang and Reza Mehvar, published online on June 1st 2009 in Wiley InterScience (www.interscience.wiley.com), has been retracted by agreement between the journal Editor in Chief, Dr Chang Kee Lim and John Wiley and Sons, Ltd. The retraction has been agreed as the research article was submitted without Dr. Mehvar's knowledge or consent. [source]

    Retraction: Blockage of intracellular proton extrusion with proton pump inhibitor induces apoptosis in gastric cancer

    CANCER SCIENCE, Issue 1 2008
    Marie Yeo
    The following article from Cancer Science, ,Blockage of intracellular proton extrusion with proton pump inhibitor induces apoptosis in gastric cancer' by Marie Yeo, Dong-Kyu Kim, Hee Jin Park, Sung Won Cho, Jae Youn Cheong and Kwang Jae Lee (doi: 10.1111/j.1349-7006.2007.00642.x), published online on 23 October 2007 on Blackwell Synergy (http://www.blackwell-synergy.com), has been retracted by agreement between the authors, the journal Editor in Chief, Takashi Tsuruo, and Blackwell Publishing. All authors wish to retract this paper because of the use of RGM-1 without the prior permission of the original establisher. Proton pump inhibitors have been used for treatment of acid-related gastroesophageal diseases and they act as potent inhibitors of gastric acid pump, H+/K+ -ATPase. Since cancer cells in vivo often exist in an ischemic microenvironment with a lower pH, maintenance of cellular pH is important for cell survival. In this study, we evaluated whether blocking of proton extrusion with proton pump inhibitors could inhibit the viability of gastric cancer cells. Treatment of human gastric cancer cells with proton pump inhibitors significantly attenuated cell viability in a time- and dose-dependent manner. The pro-apoptotic activity of proton pump inhibitors was mediated by release of cytochrome c and caspases activation. Gastric cancer cells showed the resistance to acidity of culture medium, which was related with a remarkable increase of extracellular signal-regulated protein kinase 1/2 (ERK1/2) phosphorylation in the acidic condition. This ERK1/2 phosphorylation was completely inhibited by pretreatment with proton pump inhibitors, suggesting that its inhibitory action on phosphorylation of ERK1/2 might contribute to the induction of apoptosis in gastric cancer cells. In conclusion, our results suggest novel therapeutic approaches for gastric cancer with proton pump inhibitors. (Cancer Sci 2008; 99: 185,185) [source]